Cost-effectiveness of Gatifloxacin vs Ceftriaxone With a Macrolide for the Treatment of Community-Acquired Pneumonia
- 1 May 2001
- Vol. 119 (5), 1439-1448
- https://doi.org/10.1378/chest.119.5.1439
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic SocietyClinical Infectious Diseases, 2000
- Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?American Journal Of Medicine, 1999
- Processes and Outcomes of Care for Patients With Community-Acquired PneumoniaArchives of Internal Medicine, 1999
- COMMUNITY-ACQUIRED PNEUMONIA: EPIDEMIOLOGY, ETIOLOGY, TREATMENTInfectious Disease Clinics of North America, 1998
- The cost of treating community-acquired pneumoniaClinical Therapeutics, 1998
- Community‐Acquired Pneumonia in Adults: Guidelines for ManagementClinical Infectious Diseases, 1998
- Incidence of Community-Acquired Pneumonia Requiring HospitalizationArchives of Internal Medicine, 1997
- Community-Acquired PneumoniaNew England Journal of Medicine, 1995
- Medical Section pf the American Lung Association: Guidelines for the Initial Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antimicrobial TherapyAmerican Review of Respiratory Disease, 1993